AEGON ASSET MANAGEMENT UK Plc Cuts Stock Holdings in Colgate-Palmolive Company $CL

AEGON ASSET MANAGEMENT UK Plc lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 16.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 865,624 shares of the company’s stock after selling 174,717 shares during the period. Colgate-Palmolive makes up approximately 0.8% of AEGON ASSET MANAGEMENT UK Plc’s holdings, making the stock its 27th largest holding. AEGON ASSET MANAGEMENT UK Plc owned about 0.11% of Colgate-Palmolive worth $69,258,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after purchasing an additional 993,432 shares during the period. Norges Bank purchased a new position in shares of Colgate-Palmolive in the second quarter worth $960,390,000. Invesco Ltd. increased its stake in shares of Colgate-Palmolive by 9.1% in the second quarter. Invesco Ltd. now owns 7,489,050 shares of the company’s stock worth $680,755,000 after buying an additional 621,841 shares during the period. Acadian Asset Management LLC raised its holdings in Colgate-Palmolive by 42.9% during the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock valued at $556,663,000 after buying an additional 1,839,853 shares during the last quarter. Finally, Schroder Investment Management Group boosted its position in Colgate-Palmolive by 242.3% during the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock valued at $483,962,000 after buying an additional 3,768,784 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 1.0%

Shares of Colgate-Palmolive stock opened at $86.67 on Monday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The firm has a market cap of $69.86 billion, a price-to-earnings ratio of 24.28, a PEG ratio of 5.85 and a beta of 0.30. The company has a 50-day moving average of $80.07 and a 200 day moving average of $81.43. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. The business’s revenue was up 1.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s payout ratio is presently 58.26%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Wells Fargo & Company set a $86.00 price objective on shares of Colgate-Palmolive and gave the company an “equal weight” rating in a research note on Tuesday, January 13th. Barclays set a $83.00 price target on Colgate-Palmolive in a report on Friday, January 16th. Bank of America dropped their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. TD Cowen cut their price objective on Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating on the stock in a research report on Thursday, January 8th. Finally, UBS Group upped their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday, January 14th. Eleven research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $89.44.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.